Aridis Pharmaceuticals initiated at Northland
Aridis Pharmaceuticals initiated with an Outperform at Northland. Northland analyst Carl Byrns initiated Aridis Pharmaceuticals with an Outperform and $40 price target.https://thefly.com/landingPageNews.php?id=2787949
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.